Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

François Dargent

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 21, 2006
[Prostatic sarcoma: Report of two cases]François Dargent, Pierre Colombeau, François Paraf, et al.
Basic & Clinical Pharmacology & Toxicology|April 26, 2006
Preclinical assessment of gastrooesophageal tolerance of the new antiosteoporotic drug strontium ranelate: an endoscopic study in monkeysCecile Fisch, Mahmoud Attia, François Dargent, et al.
European Urology Focus|August 2, 2021
Sacral Neuromodulation with the InterStim System for Overactive Bladder: 3-Year Results from the French Prospective, Multicenter, Observational SOUNDS StudyEmmanuel Chartier-Kastler, Loïc Le Normand, Alain Ruffion, et al.
European Urology Focus|April 5, 2023
Five-year Results from the Prospective, Multicenter, Observational SOUNDS Study of Patients with Overactive Bladder Treated with the InterStim System for Sacral NeuromodulationEmmanuel Chartier-Kastler, Loïc Le Normand, Alain Ruffion, et al.
European Urology Focus|September 10, 2020
Sacral Neuromodulation with the InterStim™ System for Intractable Lower Urinary Tract Dysfunctions (SOUNDS): Results of Clinical Effectiveness, Quality of Life, Patient-Reported Outcomes and Safety in a French Multicenter Observational StudyEmmanuel Chartier-Kastler, Loïc Le Normand, Alain Ruffion, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 21, 2006
[Prostatic sarcoma: Report of two cases]François Dargent, Pierre Colombeau, François Paraf, et al.
Basic & Clinical Pharmacology & Toxicology|April 26, 2006
Preclinical assessment of gastrooesophageal tolerance of the new antiosteoporotic drug strontium ranelate: an endoscopic study in monkeysCecile Fisch, Mahmoud Attia, François Dargent, et al.
European Urology Focus|August 2, 2021
Sacral Neuromodulation with the InterStim System for Overactive Bladder: 3-Year Results from the French Prospective, Multicenter, Observational SOUNDS StudyEmmanuel Chartier-Kastler, Loïc Le Normand, Alain Ruffion, et al.
European Urology Focus|April 5, 2023
Five-year Results from the Prospective, Multicenter, Observational SOUNDS Study of Patients with Overactive Bladder Treated with the InterStim System for Sacral NeuromodulationEmmanuel Chartier-Kastler, Loïc Le Normand, Alain Ruffion, et al.
European Urology Focus|September 10, 2020
Sacral Neuromodulation with the InterStim™ System for Intractable Lower Urinary Tract Dysfunctions (SOUNDS): Results of Clinical Effectiveness, Quality of Life, Patient-Reported Outcomes and Safety in a French Multicenter Observational StudyEmmanuel Chartier-Kastler, Loïc Le Normand, Alain Ruffion, et al.
Pageof 1